Symbiotic-Lung-01
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07222566 ↗
- Recruiting
- Pfizer
- Focused
We haven't built an HCP commentary report on Symbiotic-Lung-01 (PF-08634404 in locally advanced or metastatic non-small cell lung cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on Symbiotic-Lung-01 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 2 | |
| YouTube | 1 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- AN INTERVENTIONAL PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
- Phase
- Phase 3
- Status
- Recruiting
- Conditions
- Advanced Non-Small Cell Lung Cancer; Non-Small Cell Lung Cancer; Carcinoma, Non-Small-Cell Lung; Carcinoma, Non-Small-Cell Lung (NSCLC); Metastatic Non Small Cell Lung Cancer; Lung Cancer
- Interventions
- PF-08634404; Pembrolizumab; Chemotherapy Regimen 1; Chemotherapy Regimen 2
- Arms
- Arm A · Experimental
- Arm B · Active comparator
- Arm C · Experimental
- Arm D · Active comparator
- Enrollment
- 1,410 (estimated)
- Primary outcomes
- Overall Survival
- Progression Free Survival (PFS) assessed by blinded independent central review (BICR)
- Sponsor
- Pfizer
- Start
- Jan 6, 2026
- Primary completion
- Feb 27, 2029 (estimated)
- Results posted
- No
- Registry record
- NCT07222566 · updated Oct 8, 2026